CD3+/CD19+ depleted peripheral blood stem cells

· Children's Hospital of Philadelphia

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD3+/CD19+ depleted peripheral blood stem cells, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC [EARLY_Phase 1]